brain-cancer

Brain cells fuel glioblastoma growth—scientists find new weakness in the deadliest brain cancer.

Canadian researchers discovered that specific brain support cells can send signals that strengthen glioblastoma cancer cells and help tumors grow. When researchers blocked this cellular communication pathway, tumor growth slowed dramatically in preclinical experiments.

Brain cells fuel glioblastoma growth—scientists find new weakness in the deadliest brain cancer.

This finding identifies a new vulnerability in glioblastoma—one of the deadliest cancers with only 15 months median survival. Disrupting the signaling between brain support cells and tumor cells could be a therapeutic target.

Key Findings

Brain support cells send tumor-promoting signals to glioblastoma cells
Blocking this cell communication significantly slowed tumor growth in preclinical experiments
New therapeutic target identified in glioblastoma
Finding reveals a previously underappreciated role of brain microenvironment in GBM growth
Potential drug target for one of the deadliest cancers

Implications

This discovery opens a new research direction in glioblastoma treatment targeting tumor-brain cell communication. If the specific signaling pathway is identified and druggable, it could complement existing GBM therapies.

Caveats

ScienceDaily press release; limited detail; preclinical study; abstract-only. Specific cell type and signaling pathway not specified in abstract. Translational relevance requires extensive validation. Most GBM preclinical findings do not translate to clinical benefit.

Source: ScienceDaily Cancer — 2026-04-05

Landmark DCIS trial, CRC microbiome & AML combos

Two themes cut across this week’s 236 posts. The first is de-escalation: researchers are building rigorous evidence that patients can safely do less — skip lymph node surgery, forgo radiotherapy, watch pre-invasive lesions instead of cutting them out. The landmark result here is a randomized trial confirming that active surveillance

Colorectal Cancer Microbiome Discovery Platform

Analysis of 9,000+ patients revealed that only colorectal cancer — not other cancer types — consistently harbors distinct microbial communities, suggesting the gut microbiome has a unique relationship with colorectal carcinogenesis that could be exploited for diagnostics and treatment.

GBM Tumor Microenvironment Drug Target Atlas

Non-cancerous brain support cells were found to promote glioblastoma growth through paracrine signaling, and blocking this communication dramatically slowed tumor growth — revealing that GBM's microenvironment contains targetable vulnerabilities that are being systematically overlooked by drug…

BET Inhibitor Target Selectivity Database

BRD2 and BRD4 have fundamentally distinct functions — BRD2 prepares genes for activation while BRD4 triggers transcription — meaning that pan-BET inhibitors have been disrupting gene regulation in counterproductive ways, and the field now needs selective BRD4 inhibitors.

Brain cells fuel glioblastoma growth—scientists find new weakness in the deadliest brain cancer.

Key Findings

Implications

Caveats

Read more

Landmark DCIS trial, CRC microbiome & AML combos

Colorectal Cancer Microbiome Discovery Platform

GBM Tumor Microenvironment Drug Target Atlas

BET Inhibitor Target Selectivity Database